CEOs Suffer Through the Same Recurring Nightmare

By WallStreetDaily.com CEOs Suffer Through the Same Recurring Nightmare

When Friday rolls around in the Wall Street Daily Nation, we roll out the charts. After all, a picture is supposed to be worth a thousand words, right?

Plus, at this point in the week, you’re probably tired of reading my longwinded analysis.

So without further ado, I’ll (mostly) shut up now, as we serve up a few timely and telling graphics on the most pressing concern facing business owners, first-quarter earnings season and the outlook for stocks in the coming month.

A New Situation to Worry About

Remember when every CEO, analyst and stock market bear had us freaking out about lackluster top-line sales figures?

They swore it was an indication that American consumers would never get back to their buying ways.

And it’s impossible for an economy to grow if people and corporate entities aren’t buying goods and services.

Well, we can all chill out now. Sales figures are on the mend – rising 1.8% last year for S&P 500 companies. And top brass at corporations aren’t worried about the situation anymore.

 

The latest National Federation of Independent Business (NFIB) survey confirms that their top concern is now high-quality labor. That’s an indication of tightening labor market conditions, which means that wage inflation might be around the corner.

As I pointed out last week, wage growth is a trend that could squeeze corporate profit margins if it accelerates fast enough. By all means, keep an eye on it!

What’s the Excuse This Time?

With the first quarter in the bag, it’s time to prepare for an onslaught of earnings reports.

And as you know, companies in jeopardy of putting up disappointing results always look for a scapegoat.

Last quarter, unseasonably cold weather provided perfect cover.

After “searching through all earnings conference call transcripts for S&P 500 companies between January 1, 2014 and March 12, 2014, the term ‘weather’ was mentioned at least once in 195 conference calls,” says FactSet’s John Butters. That represents an 81% increase year over year.

The only companies that couldn’t blame poor results on bad weather appear to be in the telecom sector.

What will the most popular talking point be this quarter? Submit your best guess here. I bet you the weather still dominates.

April Showers? Not for Stocks!

Economic uncertainty. Valuation concerns. More tapering. And the first predicted dip in corporate profits since the third quarter of 2012.

Sounds like the perfect recipe for a stock market selloff, doesn’t it? Don’t bet on it!

April is historically the best-performing month for stocks.

The S&P 500 Index averaged a gain of 1.7% over the last 40 years, according to Schaeffer’s Investment Research.

The Dow has put up similarly strong results. In fact, over the last 20 and 50 years, April has been a standout month – with average gains of 2.7% and 2.2%, respectively.

 

Of course, blindly assuming stocks will rally is a mistake. But if you believe in betting with the odds strongly in your favor, bet on stocks in April.

That’s it for this week. Before you go, though, let us know what you think of this weekly column – or any of our recent work at Wall Street Daily – by going here.

Ahead of the tape,

Louis Basenese

The post CEOs Suffer Through the Same Recurring Nightmare appeared first on Wall Street Daily.

Article By WallStreetDaily.com

Original Article: CEOs Suffer Through the Same Recurring Nightmare

Henyep Capital Markets (UK) Ltd Launch HY Binary Options

By HY Markets Forex Blog

HY Binary Options is the trading name of Henyep Capital Markets Ltd.  Headquartered in the United Kingdom and licensed by the world renowned FCA.

Henyep Group of companies has been operating in the financial service industry for 35 years and are licensed and registered in multiple jurisdictions including the United Kingdom, Hong Kong and the United Arab Emirates.

HY Binary Options is the latest offering to online traders that offers the very best trading platform and service for traders wishing to make up to 82% profit** per trade in as little as 60 seconds.

To welcome new traders to HY Binary Options, clients who register an account will also receive  up to 50% bonus on their first deposit.

 

What Are Binary Options?

Binary Options are predictions on whether the value (or the price) of trading products will increase or decrease within a certain timeframe.  In order to make profit a trader needs to correctly forecast whether the price will go up or down within the given timeframe. If successful, the trader will receive a profit** of up to 82% per trade.  Unlike Forex and Contract for Difference (CFD) trading, binary options trading involves the correct prediction of whether the price will go up or down within the given timeframe.

For example, a trader invests $100 on a Day Up/Down option for EURUSD. The trader predicts that, after the determined timeframe, the Euro will be stronger VS the dollar than it is now and selects an UP option. For example the option has a payout % of 73%. If the trader predicts incorrectly he will lose the investment amount in full. However, in this case the trader predicts correctly he she will receive back his/her initial investment of $100, plus 73% of the invested amount in profit. See below:-

Invested Amount = $100
Return   = ($100×73%)+ $100
=$73 + $100 = $173
Profit = $73.

What Types of Binary Options Are Available?

Day Up/Down Binary Options
This is where traders predict the price of an asset being either higher or lower than the entry rate at expiry. The expiry time specified is within the same day as when the option is placed.

60 Seconds Binary Options
60 seconds Binary Options are very similar to a Day Up/Down Binary Options.  The major difference being that the expiry is 60 seconds after making a trade.

Long-term Options

Long term Binary Optionsprovide clients the ability to take positions that will expire in a predetermined time in the future.  Long-term options allow traders to capitalise on product volatility and take advantage of the price whilst removing the impact of short term price fluctuations.

Pairs

Pairs allow clients to choose between two products and pick which product will perform better relative to the other.

For example a trader chooses to pair Gold Vs. Silver.  As Gold is stated first in the pair, it is representing ‘Up’. As Silver is the 2nd product, it is representing ‘Down’.  In this situation the trader is speculating that the value of gold (as a percentage) will perform better than the value of silver (as a percentage) during a specific timescale.

WHY SHOULD YOU TRADE WITH HY BINARY OPTIONS?

Unlike traditional Forex and CFD trading, trading Binary Options can potentially yield significantly higher profits** within a much shorter timeframe and so provides   an attractive alternative for new and experienced traders alike.  HY Binary Options offers up to 82% payouton trades, one of the most competitive rates in the industry.

As standard, clients of HY Binary Options will receive dedicated customer support from expert industry executives to ensure that their trading experience is as simple and positive as possible.

What Products Can You Trade With HY Binary Options?

Traders can trade a multitude of products including:

Forex                      Over 25 different currency pairs;
Commodities         US Oil, Corn, Coffee and Wheat.
Stocks                     Trade blue chip and tech Stocks including Google, Apple, Facebook, Goldman Sachs and IBM
Indices                   Numerous worldwide Indices including FTSE, Dow, NASDAQ and NIKKEI.
Metals                    Gold, Silver and Palladium.

 

What If I Have No Trading Experience?

HY Binary Options offer a demo account free of charge, giving you $50,000 in simulated equity to trade across their platform.  This gives you the opportunity to become familiar with our trading platform in preparation for live trading.  While trading on a demo account you can take advantage of our customer support to ensure you become fully up to speed with our platform features and functions as well as the different types of options  and products available.

To register complete our simple registration form and start trading today from as little as $250.

When trading with HY Binary Options you’ll pay zero commissions!

We’re available on Live Chat, phone or e-mail, so feel free to contact us with any questions you may have.

Thank you for visiting HY Binary Options, enter the world of live capital markets and start trading Binary Options  today!

 

 

** Profits – Please note that Binary Options are speculative products and if your prediction is wrong, you will lose the full invested value

The post Henyep Capital Markets (UK) Ltd Launch HY Binary Options appeared first on | HY Markets Official blog.

Article provided by HY Markets Forex Blog

Technology and Innovation Means More Investment Opportunities

By MoneyMorning.com.au

It was Monday afternoon, day one of the World War D conference, and Sam Volkering took over the stage.

To kick it off, he announced he was very unhappy to be there. A couple of laughs were heard in the crowd. I initially wanted to appear on the stage as a hologram, and do the presentation back from my base in London. But the technology hasn’t progressed enough yet, so I had to fly over instead.

However, after overcoming his disappointment he accepted that the stage was where he had to be.

And the first thing he launched into — sans hologram — was the third certainty…

You see, at the start of the presentation, Sam used a well-known quote from Benjamin Franklin,‘“Only two things in life are certain. Death and taxes,” wrote Franklin. But I think there’s a third certainty in life,’ Sam told the audience.

‘In fact, the one certainty is technological advancement. Death and taxes might not even exist in a future world. But technology will.’

As Sam said, he’s not into doom and gloom reports about the global economy. It’s not that he doesn’t take economic information seriously. It’s just simply that he has a positive outlook on where technology is taking the world.

He listed six key areas that are going to be the main future tech areas to watch, starting with immersive technology. This industry is drastically altering the way we communicate with each other. As Sam said, we’ve gone from hieroglyphics, to letter writing, to phone calls and then the internet.

And thanks to the internet, you can phone someone, text, email, WhatsApp them or Viber a mate to chat.

According to Sam all of this tech will merge into immersive tech.

Enter the ‘surroundweb’

Right now, he explains, we all have our heads down in our smartphones while we’re talking. But as immersive tech becomes more common, and we adopt products like Google Glass, our posture will change back to how it should be.

Soon, we will be more connected than ever before.

The internet has been a major disruption to how we do things, but in a good way.

Following on from this, Sam pointed to the super computer he carries in his pocket — his smartphone. Demonstrating how the size has changed over the years to the crowd, he said at some point ‘you’re not even going to see the technology, it will be that small. But it will surround you.

Then he started talking about the surroundweb. This means everywhere we go, we are connected to the web. But not just an internet connection. All of our devices are talking to one another.

He used the example of being able to buy a shirt without even having to talk to a sales assistant.

It’s a simple concept, he reasoned. When you walk into a store, it registers on the phone that you’ve entered. And when by picking up a shirt off the rack, it tells your phone what you’ve done. From here, you simply just make a transfer using your e-wallet. And that’s it. Simple.

In fact, Sam said the technology is already available to do this.

However what seemed to excite Sam the most is the concept of regenerative and personalised medicine.

Technology has always been a part of medicine. ‘Remember when bloodletting and shock treatment was the latest thing in technology advancement?’ Sam asked the crowd.

How fast things have changed. Thanks to advances in technology, we are one step closer to being able to live to 150 or even 160 years old. Only those ages won’t be how you imagine them now. A 150-year old person would be the equivalent of a 50 or 60 year old today.

As Sam said, ‘Imagine, looking back and saying, “wow my eighties were fun.”

It’s possible too.

Almost a living robot

To prove how much biological technology has changed, Sam introduced this guy:


Source: Sam Volkering; World War D Conference
Click to enlarge

The only thing missing from this ‘cyborg’ is a brain, a digestive system and a liver.

His Achilles moves the ways ours do. His wrist almost has full rotation, like a human. The knees bend and the joints wiggle the way a humans’ would.

This is all part of the progression of bionics and personalised medicine. It’s enabling doctors to replace damaged organs or joints so people can lead a full life. Does this mean we’ll live forever? Sam doesn’t claim that, but it will enable us to prolong our lives.

As Sam wrapped up, he told the audience it was an exciting time to be an investor in tech and biotech. And while it’s always nice to invest in the ‘big’ projects like robots or smartphones, those aren’t always the best opportunities.

As Sam pointed out on Monday, he’s far more interested in investing in what makes the technology work: sensors, microchips, CPUs and GPUs. The ‘billions of devices’ needed to get this sort of ground-breaking tech off the ground.

Shae Smith+
For Money Morning

Editor’s Note: Next week Sam Volkering’s Tech Insider will have exclusive coverage of digital expert and author of Brave New War John Robb’s speech at WWD — where he revealed how to decrease your ‘wealth burn rate’ by tapping into a new online asset trend…you can sign up to Tech Insider here.

From the Port Phillip Publishing Library

Special Report: ASX: 15,000

Join Money Morning on Google+


By MoneyMorning.com.au

Are you Prepared for a 60% Crash in the Stock Market?

By MoneyMorning.com.au

Are you willing to risk 60% of your wealth to make 6% in the stock market?

Because that’s the risk/return ratio you are looking at right now, Vern Gowdie told the audience in the afternoon of day two at World War D.

He’s not willing to expose his family wealth to those kinds of odds…not for him, but mostly, not for his kids.

His reason for such a stark view of the markets for the foreseeable future is down to the fact that we’re at the beginning of secular bear cycle. But more on that in moment.

He began his presentation with a stark warning for the boomers in the room:

We’ve created a world of excessive debt…and we’re leaving it all to our children. The highest debt-to-GDP ratio in history, overpriced housing and tax system skewed to benefit us…this is the legacy we’re leaving our kids.

Vern’s been thinking about this ever since he sold his financial planning business back in 2008 to manage his own family wealth full time.

He recalled a gathering he attended in Nicaragua for the Bonner Family Office, where he had the chance to meet with a network of ultra-wealthy people.

Some had more wealth to manage than others, said Vern, but just like every one of us, they were all looking for answers to the same questions.

What will happen to our families when we’re no longer around? Have we built the kind of wealth we want for our children and grandchildren?

And how can we make sure that wealth is still there for them so that it can appreciate and grow?

One way to do this is to realise we are in unchartered waters. Think critically. Don’t just accept what those in the financial industry tell you as fact.

Vern recalled a conference for financial professionals he spoke at in 2006. His warning that they were in the midst of a long term secular bear market didn’t go down well.

That’s because the fund managers and brokers you deal with make their money from commissions, not their performance. So their view will always be that you should be in the market.

But what if you shouldn’t be in the market? What if it’s wholly dangerous to be in the market?

Few people take into account the downside. As Donald Trump famously said, ‘some of best investments I’ve made are the ones I didn’t make.

And Vern isn’t making any investments right now.

You see, like seasons, the markets move in cycles. They never replicate identically…but fundamentally, you know summer is hotter and winter is colder. It’s the same in the financial markets.

Secular bull markets can feature many crashes in the midst of stock market prices rising over time. Secular bear markets tend to be long term sideways movements with periodic rallies and crashes.

Right now, the US is making all time highs. Many other countries lag behind.

Question: is this a new secular bull market…or are investors all over Australia and the world investing into a market on the precipice of an almighty leg down?

We know where Vern stands. Based on past secular bull and bear markets, he’s convinced we’ll see one more major crash before a new secular bull market will begin.

In order for that to happen, the US market will need to reach a P/E ratio of below 10.

That implies a 60% fall for stock prices in the near future.

That brings me back to the question Vern asked at the start…

Are you prepared for a 60% crash in stocks?

Vern isn’t.

He likened the situation to a ship captain who can see a cyclone coming. If you know a category five storm is on its way do you risk it out to sea, or wait in the harbour for it to blow over?

You wouldn’t risk your life, so don’t do it in the market.

Vern’s putting his money firmly where his mouth is: 100% in cash.

Although he has diversified his currencies, and recommends you do too…

He moved some of his own cash into US dollars back when the Aussie was buying US$1.05. His reasoning is simple: the Aussie dollar isn’t likely to rally far if it does rally. But if it falls, the drop could deep.

So when Vern does jump into the stock market, what will he decide to do?

As he explained, he’s a ‘beta’ investor, not an ‘alpha’ investor.

Beta refers to the wider market going up as a whole.

Alpha is your ability to outperform the market by picking individual stocks. Of course, that means you have to find the ones that go up, and avoid the ones that go down. The risk is obvious. Pick a dud, and you’re in trouble.

You probably gathered by now Vern doesn’t like risk.

So he prefers beta. And besides, if you pick your bull and bear markets well, it can be immensely profitable anyway. What’s more, it’s less stressful and much easier to get cycles right than individual company prospects.

That way he’ll be ready and waiting to take advantage of the next cyclical move up, once the opportunity presents itself.

James Woodburn,
Contributing Editor, Money Morning

Join Money Morning on Google+


By MoneyMorning.com.au

NZD/JPY finds support at 88.45; might break lower

Since the bullish bounce off the 200-Day Moving Average in early February, NZD/JPY has rocketed in search for a higher swing high for the current uptrend. This week’s high at 89.89, just shy of the 90.00 handle, has the potential to be the current swing high the pair was looking for.

NZDJPY Daily 4thApril

Within the main bullish channel formed between August 2013 and the present day, the impulsive waves move inside their own channels at a much steeper angle. The latest 850 pip bullish move was no exception, with the impulsive wave reaching the main channel’s resistance on April 1st. Furthermore, on the Daily chart the pair formed a small Pin bar that day, a bearish reversal price action pattern.

NZD/JPY has now reached the first minor support levels; consequently this is the area where price will decide if the uptrend will continue or if a deeper correction is in play. The 50 Simple Moving Average is trailing just beneath the market price. Immediately below it, the previous two highs at 88.30 could become a pivot zone, adding strength for the bullish red trendline. While the pair holds above this level another run towards 90.00 is possible.

NZDJPY 4H 4thApril

A break below 88.30 points towards a deeper correction towards 86.64; where a confluence between the 200 Simple Moving average on the 4H chart and the 38.2% Fibonacci retracement form a strong support area. Even lower, NZD/JPY would end up aiming for the main channel support which will soon coincide with the 61.8% Fibonacci retracement level at 84.64.

*********
Prepared by Alexandru Z., Chief Currency Strategist at Capital Trust Markets

 

 

 

 

 

 

AlgoTrades Launches Automated ETF Trading System for Individual Investors

By Chris Vermeulen – Founder of AlgoTrades Systems

Automated ETF Trading SystemOn Tuesday April 1st AlgoTrades went live with their automated ETF trading system for investors. You may have seen their April Fools Video which was unique. This 100% hands-free investing system provides you with an option to have some of your investment capital actively invested like a professional trader so you can profit in rising, falling and even sideways market conditions.

This exchange traded fund system requires less capital and a 62.5% lower subscription fee. Because ETF’s trade like stocks and are highly popular and understood by most market participants it makes this automated trading system the perfect fit for you if want to profit in the market no matter if prices are rising or falling. And because its trades none leveraged fund’s (SPY & SH) your portfolio volatility is reduced substantially from that of leveraged investments.

The AlgoTrades ETF Trading System is a LFT system (low frequency trading), meaning it only places 30-40 trades each year. It focuses on trading with the market trend and catching the wave like patterns that form each month on the SP500 index.

Conservative trading and money management strategies are the heart of this automated ETF trading system with the casual investor’s emotions and investment capital in mind..

What Our Automated ETF Trading System Is Not

Our algorithmic trading strategies are not market-neutral, meaning we do not hedge our position because we seek to profit from the stock market. Instead, our trades are directional and typically in the direction of the major trend, whether price is moving up, down or sideways.

Investing with AlgoTrades carries the risk of loss as does with all investments.

However, we are very conscious and aware of the importance of controlling risk, and believe that trading using our algorithmic trading strategies and automated approach successfully manages risk while seeking attractive returns.

Review System Details & Stats: http://www.algotrades.net/downloads/ALGO-ETF-PRO.pdf

Start Automating Your Trading Today: http://www.algotrades.net/subscribe-algorithmic-trading-system/

Chris Vermeulen
Founder of AlgoTrades Systems

 

 

 

 

How Did High Flyers Turn into Soul Searchers? Maxim Analyst Jason Kolbert on the Highs and Lows of Biotech Valuations

After soaring more than 56% last year, the NASDAQ Biotechnology Index is down almost 15% in March. In this interview with The Life Sciences Report, Jason Kolbert of the Maxim Group points to increased approval rates and a better economic and regulatory environment as the fundamentals behind a revaluation that has occurred in the sector. Kolbert also reflects on recent concerns about pricing and policy changes that have triggered what he considers a normal, healthy correction in an otherwise robust and intact sector.

The Life Sciences Report: In a recent Equity Research Industry Report, you said, “We believe a revaluation of the sector is underway.” What is causing this revaluation and what does it mean for investors?

Jason Kolbert: The value driver in the biotech sector is better products with higher efficacy and fewer side effects, which in turn drives a higher rate of regulatory approvals. Historically, the biotechnology industry and the stocks in the space have had the essence of gambling揺igh risk and high reward. A company’s success and performance largely hinge on its ability to develop a pipeline of drugs and to achieve regulatory approval [i.e., survive the regulatory environment擁n this case the U.S. Food and Drug Administration [FDA]]. The fact that the number of FDA approvals for the past three years has been trending positively is a great sign for the biotechnology space. Forbes reported that the FDA has quickened its pace of new drug approvals, approving an average of 32 new drugs annually over the past three years, significantly higher than the historical annual average of 24 from 2000 to 2010. We believe these higher numbers may continue over the next few years.

TLSR: Was the upward trend based solely on the number of drugs being approved?

JK: Industry success hinges on much more than just quantity. The quality of drugs being approved makes a huge difference.

TLSR: What are some examples of drugs that could be an improvement over the current standard of care?

JK: Industry experts and the management teams of the companies we follow tell us that recently approved drugs like Gilead Sciences Inc.’s (GILD) Sovaldi and Medivation Inc.’s (MDVN) Xtandi, as well as those still in the pipeline, have the potential to offer significant improvements over existing alternatives, and bolster both industry sales and investor confidence. In the cell therapy space, we believe that Mesoblast Ltd.’s (MEOBF) [MSB:ASE; MBLTY:OTCPK] Revascor has the potential to completely change existing treatment paradigms.

TLSR: Why does it seem that more of the drugs in the pipeline today are targeting rare diseases?

JK: This is an important shift in the drug development field. These drugs are granted special status by the FDA. The result is limited competition, enhanced intellectual property life and an increase on the return on investment. Furthermore, these drugs are able to access a more favorable regulatory pathway designed for therapies that represent a significant advance over standard of care, or an overall benefit to society. The result is an accelerated development-and-approval timeline to market. With a growing portion of drugs fitting into this category, we expect to see further outperformance in the sector.

TLSR: Why have we seen more merger-and-acquisition [M&A] activity recently?

JK: The recent $25 billion acquisition of Forest Laboratories Inc. (FRX) by major specialty pharmaceutical company Actavis Inc. (ACT) may be partly responsible for the increase in valuations for related companies, such as Teva Pharmaceutical Industries Ltd. (TEVA). A growing proportion of these large-cap pharmaceutical and biotech companies are engaging in M&A activities as they seek out size and achieve efficiency of scale. The large caps are often focused on smaller companies in the rare disease drug arenas for the reasons we’ve already mentioned, to help compensate for projected revenue losses resulting from the recent expirations of key patents.

TLSR: The biotech initial public offering [IPO] market has been active in the last year after some lean years for new public company launches. What is behind that change?

JK: We saw 37 life science companies go public in 2013, and 24 IPOs have already been underwritten this year. We see several underlying drivers. First, M&A activity has reduced the number of publicly traded small and or independent biotechnology companies. This limited supply has led to a high demand for small- and mid-cap names and, in turn, driven an oversubscription of many of the recent offers. This only encourages an already robust IPO market.

We also note that generalist fund managers and even individual investors have been increasing their exposure to the biotechnology industry, driven by an increased risk appetite and eagerness to chase high-return profiles. The rise of stocks like Pharmasset Inc. [acquired by Gilead] helped drive this trend. The success of Intercept Pharmaceuticals Inc. (ICPT) is another example of the risks and rewards that the sector offers to investors [which make it unique in the field]. The significant outperformance of the sector and the IPOs over the past year have caused generalists who otherwise normally shun the volatility of the space to get involved, generating an even greater demand for new biotechnology IPOs.

Last but not the least, the Jumpstart Our Business Startups [JOBS] Act allows companies to prepare IPOs and test the waters to determine interest. This is one of many factors that have effectively reduced risk for companies looking to go public. The act has been a catalyst for a large number of the offerings this year熔fferings that have been accumulating in the pipeline over the last few years as companies had difficulties accessing capital markets. As such, an economic recovery, a favorable regulatory environment and the JOBS Act have fostered a robust IPO marketplace in the sector.

TLSR: Has all of this good news come to an end? What has happened over the last week or so to cause the sharp pullback we saw in the space?

JK: I think we are seeing a normal, healthy correction. Markets and sectors don’t go straight up. Biotech markets got a shock when letters from congressmen questioned the price of Gilead’s Sovaldi as an expensive new drug for hepatitis C. What these letters fail to take into consideration is the overall efficacy and pharmacoeconomic value of new therapies like Sovaldi, which work better and have fewer side effects than predecessors.

TLSR: When can we expect a return to upward valuations based on the fundamentals you have outlined?

JK: Predicting biotechnology cycles has been close to impossible. The sector performed well in the late 1990s and early 2000s, and poorly in the late 2000s, and it has come back strong these past three years. The performance of the space seems correlated to both the overall economic conditions and macroeconomic policies. When there is more liquidity, and thus more easy money in the market, people tend to be increasingly willing to bet on the biotech industry, hoping that at least one of the companies they invest in will receive FDA approval for a drug that will become a blockbuster, in turn driving outperformance and revaluation of the originator company.

Despite the increase in success stories these last few years, just a small fraction of companies were developing new drugs. While a large portion of recent outperformance has come from successful drug innovation and higher FDA approval rates, it also resulted from favorable monetary policy. As monetary policies may shift, this could dampen enthusiasm for biotechnology companies.

This ties into a concern about whether the sector has the ability to retain investor interest and confidence. Further events that could trigger weakness across the sector include price controls for what some people deem expensive therapies [such as Gilead’s Sovaldi], the pace of innovation and the outcomes of clinical trials, such as Vertex Pharmaceuticals Inc.’s (VRTX) combination trials in cystic fibrosis. Clinical failures, slowing industry growth and increased regulatory risk remain factors to watch as new targeted therapies with high efficacy rates and fewer side effects also progress to the marketplace.

TLSR: Thank you for your time and comments.

This interview was conducted by the editors of Streetwise Reports and can be read in its entirety here.

Jason Kolbert has worked extensively in the healthcare sector as product manager for a leading pharmaceutical company, as a fund manager and as an equity analyst. Prior to joining Maxim Group, where he is head of healthcare research, senior managing director and biotechnology analyst, Kolbert spent seven years at Susquehanna International Group, where he managed a healthcare fund and founded SIG’s biotechnology team. Previously, Kolbert served as the healthcare strategist for Salomon Smith Barney. He is often quoted in the media and is a sought-out expert in the biotechnology field. Prior to beginning his Wall Street career, Kolbert served as a product manager for Schering-Plough in Osaka, Japan. He received a bachelor’s degree in chemistry from State University of New York, New Paltz, and a master’s degree in business administration from the University of New Haven.

DISCLOSURE:

1) The following companies mentioned in the interview are sponsors of Streetwise Reports: None. Streetwise Reports does not accept stock in exchange for its services.

2) Jason Kolbert: I own, or my family owns, shares of the following companies mentioned in this interview: None. I personally am, or my family is, paid by the following companies mentioned in this interview: None. My company has a financial relationship with the following companies mentioned in this interview: None. I was not paid by Streetwise Reports for participating in this interview. Comments and opinions expressed are my own comments and opinions. I had the opportunity to review the interview for accuracy as of the date of the interview and am responsible for the content of the interview.

3) Interviews are edited for clarity. Streetwise Reports does not make editorial comments or change experts’ statements without their consent.

4) The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer.

5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their families are prohibited from making purchases and/or sales of those securities in the open market or otherwise during the up-to-four-week interval from the time of the interview until after it publishes.

 

 

 

EUR/JPY slides back below 143 as resistance holds

Following the ECB Press Conference and their decision to leave the interest rate unchanged at the history low level of 0.25%, EUR/JPY turned bearish after reaching 143.41 and failing to take out yesterday’s high.

Technical Analysis

EURJPY Daily 3April

The long term bullish trend is intact. Until yesterday it seemed EUR/JPY would continue higher within the current bullish channel, towards 145.50. Intraday action was concentrated around the resistance trendline, yet the daily bar failed to close above it. This scenario was played all over today with the same result.

As the pair failed for the third time to create a higher high, the triangle formation looks more genuine and EUR/JPY may be forced to retreat lower yet again. The pair is quickly approaching the tip of the triangle; the range will get smaller each day, so a major breakout is due very soon.

143.46 is the main resistance. 143.77, the high from March, is a close secondary resistance.

The support of the triangle formation is extremely well defined by the 50 and the 100-Day Moving Averages in the 140.60 region, followed by the 139.95-140.00 large round number support.

*********
Prepared by Alexandru Z., Chief Currency Strategist at Capital Trust Markets

 

 

 

 

What Is Worse Than Being at Risk?

By Dennis Miller

You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” In that same vein: What is worse than being at risk? You guessed it! Not knowing you’re at risk.

For many investors, portfolio diversification is just that. They think they are protected, only to find out later just how at risk they were.

Diversification is the holy grail of portfolio safety. Many investors think they are diversified in every which way. They believe they are as protected as is reasonably possible. You may even count yourself among that group. If, however, you answer “yes” to any of the following questions, or if you are just getting started, I urge you to read on.

  • Did your portfolio take a huge hit in the 2008 downturn?
  • Was your portfolio streaking to new highs until the metals prices came down a couple years ago?
  • Do oil price fluctuations have a major impact on your portfolio?
  • When interest rates tanked in the fall of 2008, did a major portion of your bonds and CDs get called in?
  • Are you nervous before each meeting of the Federal Reserve, wondering how much your portfolio will fluctuate depending on what they say?
  • Has your portfolio grown but your buying power been reduced by inflation?
  • Do you still have a tax loss carry forward from a stock you sold more than three years ago?

There are certain lessons most of us learn the hard way—through trial and error. But that can be very expensive. Ask anyone who has a loss carry forward and they will tell you that the government is your business partner when you are winning. When you are losing, you are on your own.

The old saying rings true here: “When the student is ready to learn, the teacher shall appear.” Sad to say, for many investors that happens after they have taken a huge hit and are trying to figure out how to prevent another one.

Alas, there is an easier way. Anyone who has tried to build and manage a nest egg will agree it is a long and tedious learning experience. The key is to get educated without losing too much money in the meantime.

Avoid Catastrophic Losses

The goal of diversification is to avoid catastrophic losses. In the past, we’ve mentioned correlation and shared an index related to our portfolio addition. The scale ranges from +1 to -1. If two things move in lockstep, their correlation rates a +1. If the price of oil goes up, as a general rule the price of oil stocks will also rise.

If the two things move in the opposite direction (a correlation of -1), we can also predict the results. If interest rates rise, long-term bond prices will fall and generally so will the stocks of homebuilders.

At the same time, a correlation of zero means there is no determinable relationship. If the price of high-grade uranium goes up, more than likely it will not affect the market price of Coca-Cola stock. So, your goal should be to minimize the net correlation of your portfolio so no single event can negatively impact it catastrophically.

General Market Trends

An investor with mutual funds invested in Large Cap, Mid Cap, and Small Cap stocks may think he is well diversified with investments in over 1,000 different companies. Ask anyone who owned a stable of stock mutual funds when the market tumbled in 2008 and they will tell you they learned a lesson.

Mr. Market is not known to be totally rational and many have lost money due to “guilt by association.” When the overall stock or bond market starts to fall, even the best-managed businesses are not immune to some fallout. While the Federal Reserve has pumped trillions of dollars into the system, there is no guarantee the market will rebound as quickly as it has in the last five years. The market tanked during the Great Depression and it took 25 years to return to its previous high.

If you listen to champions of the Austrian business cycle theory, they will tell you the longer the artificial boom, the longer and more painful the eventual bust. Mr. Market can dish out some cruel punishment.

Diversification is indeed the holy grail, but there are some risks which diversification cannot mitigate entirely. No matter how hard you try to fortify your bunker, sooner or later we will learn of a bunker buster. There are times when minimizing the damage and avoiding the catastrophic loss is all anyone can do.

Sectors

Allocating too much of your portfolio to one sector can be dangerous. This is particularly true if a single event can happen that could give you little time to react. While no one predicted the events of September 11, people who held a lot of airline stocks took some tough losses. Guilt by association also applied here. After September 11, the stocks of the best-managed airlines, hotels, and theme parks took a downturn.

When the tech bubble and real estate bubble burst, the stock prices of the best-run companies dropped along with the rest of the sector, leaving investors to hope their prices would rebound quickly.

Geography

One of the major factors to consider when investing in mining and oil stocks is where they are located. It is impossible to move a gold mine or an oil well that has been drilled. Many governments are now imposing draconian taxes on these companies, which negatively impacts shareholders. In some cases, this can be a correlation of -1. If an aggressive government is affecting a particular oil company, other companies in different locations may have to pick up the slack and their stock may rise in anticipation of increased sales.

Many governments around the world have become very aggressive with environmental regulation, costing the industry billions of dollars to comply. If you want to invest in companies that burn or sell anything to do with fossil fuels, you would do well to understand the political climate where their production takes place.

Investors who prefer municipal bonds must make their own geographical rating on top of the ratings provided for the various services. States like Michigan and Illinois are headed for some rough times. I wouldn’t be lending any of them my money in the current environment no matter what the interest rate might be.

Currency Issues

Inflation is public enemy number one for seniors and savers. One of the advantages of currencies is they always trade in pairs. If one currency goes up, another goes down. If the majority of your portfolio is in one currency, you are well served to have investments in metals and other vehicles good for mitigating inflation.

Tim Price sums it up this way in an article posted on Sovereign Man:

“Why do we continue to keep the faith with gold (and silver)? We can encapsulate the argument in one statistic.

“Last year, the US Federal Reserve enjoyed its 100th anniversary. … By 2007, the Fed’s balance sheet had grown to $800 billion. Under its current QE program (which may or may not get tapered according to the Fed’s current intentions), the Fed is printing $1 trillion a year. To put it another way, the Fed is printing roughly 100 years’ worth of money every 12 months. (Now that’s inflation.)”

It is difficult to determine when the rest of the world will lose faith in the US dollar. Once one major country starts aggressively unloading our dollars, the direction and speed of the tide could turn quickly.

Interest-Rate Risk

The Federal Reserve plays a major role in determining interest rates. Basically they have instituted their version of price controls and artificially held interest rates down for over five years. Interest-rate movement affects many markets: housing, capital goods, and some aspects of the bond markets. While it also makes it easier for businesses to borrow money, they are not likely to make major capital expenditures when they are uncertain about the direction of the economy.

While holders of long-term, high-interest bonds had an unexpected gain when the government dropped rates, their run will eventually come to an end as rates rise. Duration is an excellent tool for evaluating changes in interest rates and their effect on bond resale prices and bond funds. (See our free special report Bond Basics, for more on duration.)

While interest rates have been rising, when you factor in duration there is significant risk, even with the higher interest offered for 10- to 30-year maturities. Again, having a diversified portfolio with much shorter-term bonds helps to mitigate some of the risk.

Risk Categories of Individual Investments

While investors have been looking for better yield, there has been a major shift toward lower-rated (junk) bonds. Many pundits have pointed out that their default rate is “not that bad.”

At the same time, the lure of highly speculative investments in mining, metals, and start-up companies with good write-ups can be very appealing. There is merit to having small positions in both lower-rated bonds and speculative stocks because they offer terrific potential for nice gains.

So What Can Income Investors Do?

There are a number of solid investments out there that offer good return, with a minimal amount of risk exposure and that won’t move because of an arbitrary statement by the Fed. It’s not always easy to find them, but there is hope for people wondering what to do now that all of the old adages about retirement investing are no longer true.

There are three important facets of a strong portfolio: income, opportunities and safety measures. Miller’s Money Forever helps guide you through the better points of finance, and helps replace that income lost in our zero-interest-rate world—with minimal risk.

This is where the value of one of the best analyst teams in the world comes into focus. We focus on our subscribers’ income-investing needs, and I challenge our analysts to find safe, decent-yielding, fixed-income products that will not trade in tandem with the steroid-induced stock market—or alternatively, ones that will come back to life quickly if they do get knocked down with the market. They recently showed me seven different types of investments that met my criteria and still withstood our Five-Point Balancing Test.

My peers are of having holes blown in their retirement plans. While nuclear-bomb-shelter safe may be impossible, we still want a bulletproof plan.

This is what we’ve done at Money Forever: built a bulletproof, income-generating portfolio that will stand up to almost anything the market can throw at it.

It is time to evolve and learn about the vast market of income investments safe enough for even the most risk-wary retirees. Some investors may want to shoot for the moon, but we spent the bulk of our adult lives building our nest eggs; it’s time to let them work for us and enjoy retirement stress-free. Learn how to get in, now.

 

 

The article What Is Worse Than Being at Risk? was originally published at millersmoney.com.

Gold Prices Climbs from Seven-Week Low

By HY Markets Forex Blog

Futures for gold were seen climbing higher for a second day in a row on Thursday, before the release of the US non-farm payrolls report due on Friday.

The anticipating US non-farm payrolls report could enlighten the current state of the world’s largest economy and may hint the next step the Federal Reserve (Fed) may take on its monthly asset purchases.

Gold prices held a rise from its seven-week low, edging 0.21% higher at $1,293.70 an ounce at the time of writing, climbing from February’s low of $1,277.58 seen in the previous week.

Holdings in the world’s largest gold-backed exchange-traded fund, SPDR Gold Trust; came in at 810.98 tons on Wednesday, the lowest since the first week of March.

“The last two days have seen outflows from gold ETFs total 8.8 tons. Clearly, investments are being shifted from gold into equities. The S&P 500, for example, closed at a record high yesterday, while other equity markets are likewise not far from reaching record highs or finding themselves on a pronounced upward trajectory,” Commerzbank quoted on Wednesday.

Gold – US Jobs Report

The ADP employment report released on Wednesday, showed that 191,000 new jobs were added to the US private sector in the month of March, compared to the revised 178,000 seen in February.

The anticipating jobs report may hint the Federal Reserve‘s next move on its monetary policy, as the US Federal Reserve trimmed asset purchases at the last three policy meetings.  The jobs data tomorrow is expected to show a positive growth in the jobs sector, with analysts expecting to see 200,000 new jobs added to the US economy in March.

On Wednesday, the President of the Fed Bank of St. Louis James Bullard said that reducing the benchmark interest rate further could halt trimming bond purchases, which is not likely to happen, according to Bullard.

 

Visit www.hymarkets.com   to find out more about our products and start trading today with only $50 using the latest trading technology today

The post Gold Prices Climbs from Seven-Week Low appeared first on | HY Markets Official blog.

Article provided by HY Markets Forex Blog